Future Directions in Small Cell Lung Cancer Treatment

The final episode of CancerNetwork’s 4-part series on small cell lung cancer (SCLC) welcomes back Wade Iams, MD, a thoracic medical oncologist at the Vanderbilt University Medical Center. In this conversation, Iams looks to the future of SCLC treatments, touching on topics including extending response durations for patients, emerging therapies for extensive stage SCLC, exciting research on the horizon, and more.

Don’t forget to subscribe to the "Oncology Peer Review On-The-Go" podcast on Apple Podcasts, Spotify, or anywhere podcasts are available.

Check out the previous podcast episodes in this series:

·      Episode 1: First-Line Therapeutic Options in Small Cell Lung Cancer

·      Episode 2: Treatment Options for Relapsed/Refractory Small Cell Lung Cancer

·      Episode 3: Practical Considerations for Small Cell Lung Cancer Therapeutic Options